Vimarsana
Biggest News Aggregation in the World

Page 2 - Improvement Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Improvement Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Improvement Act Today - Breaking & Trending Today

United States - Compliance - Whistleblower Awards For Auditors Are Key To Meeting OECD Guidelines - Vimarsana News

United States - Compliance - Whistleblower Awards For Auditors Are Key To Meeting OECD Guidelines

According to the Institute of Internal Auditors "Politics of Internal Auditing" (2015), 55% of chief audit executives were directed to commit important findings from their audit reports.

Source: mondaq.com
United States - Money Laundering - FinCEN Head Praises New AML Whistleblower Program - Vimarsana News

United States - Money Laundering - FinCEN Head Praises New AML Whistleblower Program

The passage of the Anti-Money Laundering (AML) Whistleblower Improvement Act in December 2022 was heralded by whistleblower advocates as a major development...

Source: mondaq.com
Justice Dept plans to reschedule marijuana as a lower-risk drug - Vimarsana News

Justice Dept plans to reschedule marijuana as a lower-risk drug

The historic move acknowledges the medical benefits of the drug and carries broad implications.

Source: yahoo.com
Opinion: Consumer interest in cannabinoids grows | Agri-Pulse Communications, Inc. - Vimarsana News

Opinion: Consumer interest in cannabinoids grows | Agri-Pulse Communications, Inc.

In this opinion piece, Nathan Sukhov, Manager of Rogue Origin, 

DOJ plans to move to reschedule marijuana as a lower-risk drug - Vimarsana News

DOJ plans to move to reschedule marijuana as a lower-risk drug

The Biden administration will move Tuesday to reclassify marijuana as a lower-risk substance, a person familiar with the plans told CNN, a historic move that acknowledges the medical benefits of the long-criminalized drug and carries broad implications for cannabis-related research and the industry at large.

Source: cnn.com